RxDoctor Payments DataLook up a doctor →

Nima Aghili, MD

Interventional Cardiology · Lakewood, CONPI 1043487655

Payments from drug & device makers

$221,057in general payments, 2019–2025

Across 892 payments — averaging $247.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abiomed$113K
  • Johnson & Johnson$56K
  • Boehringer Ingelheim$17K
  • Medtronic$13K
  • Abbott$4K
  • Boston Scientific$3K
  • plus $16K from 46 others
$350in research payments, 2019–2025

Across 3 payments — averaging $116.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abiomed$350

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$221,057 in reported general payments places this provider in the 85th percentile of 111 interventional cardiology providers in Colorado.

See all interventional cardiology providers in Colorado

Medicare billing

Part B allowed, 2024
$271,762
Medicare patients
813
Services billed
2,836

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Lakewood

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →